McKesson Debt to Equity Ratio 2010-2024 | MCK
Current and historical debt to equity ratio values for McKesson (MCK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. McKesson debt/equity for the three months ending September 30, 2024 was 0.00.
| McKesson Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-09-30 |
$75.07B |
$-2.64B |
-28.41 |
| 2024-06-30 |
$73.05B |
$-1.38B |
-52.90 |
| 2024-03-31 |
$69.04B |
$-1.60B |
-43.18 |
| 2023-12-31 |
$68.19B |
$-1.68B |
-40.54 |
| 2023-09-30 |
$67.56B |
$-1.46B |
-46.14 |
| 2023-06-30 |
$65.34B |
$-1.24B |
-52.69 |
| 2023-03-31 |
$63.81B |
$-1.49B |
-42.83 |
| 2022-12-31 |
$64.78B |
$-2.09B |
-31.01 |
| 2022-09-30 |
$64.33B |
$-1.25B |
-51.51 |
| 2022-06-30 |
$63.77B |
$-1.47B |
-43.32 |
| 2022-03-31 |
$65.09B |
$-1.79B |
-36.32 |
| 2021-12-31 |
$64.50B |
$-0.79B |
-81.95 |
| 2021-09-30 |
$63.69B |
$-0.09B |
-732.05 |
| 2021-06-30 |
$62.94B |
$-0.05B |
-1398.64 |
| 2021-03-31 |
$64.84B |
$0.18B |
370.51 |
| 2020-12-31 |
$62.12B |
$-0.28B |
-224.27 |
| 2020-09-30 |
$55.47B |
$6.09B |
9.11 |
| 2020-06-30 |
$52.01B |
$5.65B |
9.20 |
| 2020-03-31 |
$55.94B |
$5.31B |
10.54 |
| 2019-12-31 |
$54.49B |
$6.39B |
8.53 |
| 2019-09-30 |
$52.30B |
$6.69B |
7.82 |
| 2019-06-30 |
$53.61B |
$8.07B |
6.65 |
| 2019-03-31 |
$51.39B |
$8.29B |
6.20 |
| 2018-12-31 |
$51.62B |
$9.39B |
5.50 |
| 2018-09-30 |
$51.89B |
$9.53B |
5.44 |
| 2018-06-30 |
$51.64B |
$9.65B |
5.35 |
| 2018-03-31 |
$50.32B |
$10.06B |
5.00 |
| 2017-12-31 |
$52.24B |
$11.97B |
4.36 |
| 2017-09-30 |
$52.48B |
$11.36B |
4.62 |
| 2017-06-30 |
$50.30B |
$11.51B |
4.37 |
| 2017-03-31 |
$49.70B |
$11.27B |
4.41 |
| 2016-12-31 |
$50.02B |
$7.85B |
6.37 |
| 2016-09-30 |
$48.69B |
$9.62B |
5.06 |
| 2016-06-30 |
$48.41B |
$9.49B |
5.10 |
| 2016-03-31 |
$47.52B |
$9.01B |
5.28 |
| 2015-12-31 |
$46.13B |
$8.96B |
5.15 |
| 2015-09-30 |
$46.95B |
$8.87B |
5.29 |
| 2015-06-30 |
$46.99B |
$8.94B |
5.26 |
| 2015-03-31 |
$45.79B |
$8.09B |
5.66 |
| 2014-12-31 |
$45.95B |
$9.16B |
5.02 |
| 2014-09-30 |
$41.71B |
$10.53B |
3.96 |
| 2014-06-30 |
$42.24B |
$10.77B |
3.92 |
| 2014-03-31 |
$41.44B |
$10.32B |
4.02 |
| 2013-12-31 |
$28.45B |
$8.03B |
3.55 |
| 2013-09-30 |
$27.96B |
$7.99B |
3.50 |
| 2013-06-30 |
$28.08B |
$7.41B |
3.79 |
| 2013-03-31 |
$27.72B |
$7.07B |
3.92 |
| 2012-12-31 |
$25.78B |
$7.65B |
3.37 |
| 2012-09-30 |
$25.25B |
$7.72B |
3.27 |
| 2012-06-30 |
$24.55B |
$7.20B |
3.41 |
| 2012-03-31 |
$26.26B |
$6.83B |
3.85 |
| 2011-12-31 |
$25.70B |
$7.46B |
3.45 |
| 2011-09-30 |
$24.79B |
$7.12B |
3.48 |
| 2011-06-30 |
$24.10B |
$6.92B |
3.48 |
| 2011-03-31 |
$23.67B |
$7.22B |
3.28 |
| 2010-12-31 |
$23.32B |
$7.08B |
3.29 |
| 2010-09-30 |
$19.98B |
$6.82B |
2.93 |
| 2010-06-30 |
$20.52B |
$6.88B |
2.98 |
| 2010-03-31 |
$20.66B |
$7.53B |
2.74 |
| 2009-12-31 |
$20.42B |
$7.12B |
2.87 |
| 2009-09-30 |
$19.91B |
$6.72B |
2.96 |
| 2009-06-30 |
$19.45B |
$6.27B |
3.10 |
| 2009-03-31 |
$19.07B |
$6.19B |
3.08 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$78.780B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
